Purpose: To understand the long-term neurological outcomes and chronological changes of brain MRIs in patients with febrile infection-related epilepsy syndrome (FIRES). Methods: From December 2000 to May 2016, 29 patients diagnosed with FIRES were collected retrospectively. The demographic distribution, clinical manifestations, neuroimaging findings, and treatment methodology were described. Follow-up clinical outcomes and chronological evolution of neuroimaging findings were analyzed. Results: The median age of disease onset was 8.9 years. The median duration of hospitalization was 87 days. During the period of hospitalization, more than 50% of patients exhibited complications such as skin rash, liver function impairment, and arrhythmia. Abnormal findings were found in 38% of neuroimaging studies in the initial study and in 87% of the follow-up brain MRI. Focal abnormal signal changes over the periventricular white matter suggested the more extensive lesions would be associated with a poorer clinical outcome. The median duration of follow-up was 5 years in 23 patients. In total, 87% of patients exhibited residual and/or refractory epilepsy. Regarding cognitive function, 26% of patients had normal intelligence quotient, 26% had learning disability and mild to moderate mental retardation, and 48% had severe mental retardation or vegetative status. The mortality rate at acute stage was 10%, and that at chronic stage was 13%. Conclusions: Liver function impairment, skin rash, and arrhythmia are frequently seen during hospitalization for FIRES at the acute stage of disease course. The higher grade of periventricular white matter lesions suggested poorer neurological outcomes. Studies on the pathomechanism of FIRES are crucially needed so that new treatment strategies for FIRES can be developed, which may improve long-term outcomes.
Introduction
Febrile infection-related epilepsy syndrome (FIRES) is a catastrophic epileptic encephalopathy with known febrile infection preceding the onset of refractory status epilepticus, but without evidence of identified infectious encephalitis. Various names have been proposed for this entity, including acute encephalitis with refractory repetitive partial seizures (AERRPS) [1] , new-onset refractory status epilepticus (NORSE) [2] , devastating epileptic encephalopathy in school-age children (DESC) [3] , fever-induced refractory epileptic encephalopathy in school-age children (FIRES) [4] , febrile infection-related epilepsy syndrome (FIRES) [5] , and fulminant inflammatory response epilepsy syndrome (FIRES) [6] . In 2011, it was proposed that these conditions represent the same epileptic entities [7] . Infectious mechanisms, inflammatory-mediated process, metabolic diseases, monogenic epilepsy genes, genetic predisposition, and autoimmunity have been proposed as the pathogenic mechanisms of FIRES [4, 5, 8] , but the etiology remains unknown.
Patients with this entity share common clinical characteristics [1, 5, 9, 10] , including a febrile infection preceding the onset of the acute phase with prolonged duration of refractory status epilepticus, usually lasting days to months, followed by the chronic phase with refractory epilepsy and neurological impairment, without a silent period between the two phases, in previously healthy children [11] . Clinical seizures of these patients are mainly focal seizures with or without evolving to bilateral convulsive seizures, which occur in a repetitive and refractory manners despite intensive treatment with multiple antiepileptic drugs, immunosuppressive agents, a ketogenic diet, and/or burst-suppression coma. The initial brain magnetic resonance imaging (MRI) findings are often normal, with the proportion from 41% to 55% [5, 9, 12] . Abnormal signal changes are detectable in some patients, predominantly in the temporal regions, the insula, the basal ganglia, and/or the thalami, and the follow-up brain MRI features may show generalized brain atrophy [9] . The clinical outcome of FIRES is devastating, usually with a high mortality rate, cognitive function decline, or severe neurological sequelae.
Neurological outcomes of FIRES have been reported in Western countries and Japan [1, 5, 9, 10, 12] . Here, we describe the long-term follow-up clinical outcome and chronological evolution of brain MRI findings in children with FIRES in Taiwan.
Methods

Diagnostic criteria
The inclusion criteria of FIRES in our study were 1) acute onset of the first seizure 2 to 10 days after antecedent febrile illness in previously healthy children, 2) frequent seizures evolving into refractory status epilepticus, 3) the absence of identified pathogen in cerebrospinal fluid (CSF), 4) prolonged acute phase of more than two weeks, 5) persistent fever during the acute phase of illness, and 6) continuous switchover to refractory epilepsy without a latent period. The exclusion criteria were children with 1) prior unprovoked seizures, 2) previously reported seizures caused by a known neurologic disease, 3) developmental delay, 4) structural lesions on magnetic resonance imaging (MRI), and 5) identification of an infectious agent in blood or CSF.
Investigation workups
For all study subjects, routine blood analysis, arterial blood gas, selective serology tests including herpes simplex virus (HSV) IgG/ IgM, Epstein-Barr virus (EBV) IgG/IgM, Mycoplasma pneumoniae particle agglutination (PA) and IgM, complement-fixation (CF) antibodies to influenza virus and adenovirus, throat viral culture, and CSF studies including cell count, viral culture, and polymerase chain reaction (PCR) for HSV, were conducted. Metabolic survey, including lactate, ammonia, and assays of tandem mass spectroscopy, plasma amino acids, urinary organic acids, and carnitine level, were performed. Immunologic studies, including immunoglobulins A, G, and M, thyroid and parathyroid functions, antithyroid autoantibodies, antinuclear antibody, complement components 3 and 4, and antiphospholipid and anticardiolipin antibodies, were analyzed. In order to exclude autoimmune encephalitis, blood and CSF autoantibodies, including NMDA receptor antibody, AMPA receptor antibody, glutamic acid decarboxylase (GAD) antibody, and leucine-rich glioma inactivated 1 (LGI1), were tested in 2 patients. Genetic mutations were tested, including 2 female patients who were tested for the PCDH19 gene, and 3 patients who were tested for the SCN1A mutation. All of the patients underwent electroencephalography (EEG) and neuroimaging studies, including brain computed tomography (CT) or brain MRI within 3 days of admission.
Neuroimaging studies were followed up based on clinical evolution. In our case series, we described the most obvious abnormality on the follow-up brain MRI performed within 6 months after the disease onset. High signal intensity over the periventricular white matter, a characteristic abnormal brain MRI finding in our case series, with 0%, 1-24%, 25-49%, and !50% lesion involvement were classified as grades 0-3, respectively. The extent of the involved lesion was calculated based on the distance from the lesion to the frontal horn of the lateral ventricle divided by the distance from the subcortical white matter to the frontal horn of the lateral ventricle Â 100% (Fig. 1a ). The cognitive function was scored using an intelligence quotient test [Wechsler Intelligence Scale for Children-Revised (WISC-R)].
Data analysis
This was a retrospective study. From December 2000 to May 2016, 29 patients, 14 previously published [13] and 15 unpublished, diagnosed with FIRES were collected. The demographic distribution, clinical manifestations, neuroimaging findings, and treatment methodology were described. Follow-up neurological outcomes, including seizure intractability and cognitive functions, and chronological evolution of neuroimaging findings were analyzed. This study was approved by Institutional Review Board. 
Results
All patients and their characteristics, investigations, treatments, and outcomes are shown in Tables 1 and 2 . The demographic data, clinical manifestations, initial neuroimaging findings, and treatment methods are summarized in Table 3 . Twenty-nine patients, 12 males and 17 females, were enrolled. The median age of disease onset was 8.9 years, ranging from 1.2 to 17.8 years. The two most common symptoms of antecedent febrile illness were fever (93%; 27/29) and upper respiratory tract infection (72%; 21/29). The median duration between antecedent febrile illness and seizure onset was 6 days, ranging from 2 to 14 days. Eighty-six percent (25/29) of patients exhibited initially focal seizures evolving to bilateral convulsive seizures. Thirty-one percent (9/29) of patients showed mild CSF pleocytosis. The median duration of hospitalization was 87 days, ranging from 24 to 220 days. During the period of hospitalization, 97% (28/29) of patients needed intubation, and the median duration of intubation was 48 days, ranging from 11 days to long-term use of tracheostomy tube. More than one half of the patients exhibited complications such as skin rash with or without evolving into StevenJohnson syndrome (59%; 17/29), liver function impairment (59%; 17/29), and arrhythmia (52%; 15/29) including ventricular tachycardia, ventricular fibrillation, paroxysmal supraventricular tachycardia, and/or torsades de pointes. All patients showed refractory and repetitive seizures despite multiple traditional antiepileptic drugs (AEDs) administration. Other treatment methods tried in our case series included heavy sedation (but not burst suppression coma) (100%; 29/29), ketogenic diet (24%; 7/29), intravenous immunoglobulin (IVIg) (14%; 4/29), steroid (10%; 3/29), intravenous lidocaine (10%; 3/29), and therapeutic hypothermia therapy (7%; 2/29).
With regard to the neuroimaging studies, one patient received brain CT and the others underwent brain MRI. The first neuroimaging study at disease onset showed 62% (18/29) of patients exhibited normal results, and 38% (11/29) had abnormal findings with presentations of leptomeningeal enhancement, or signal changes over the thalami, hippocampi, or temporal lobes on the brain MRI. Twenty-three patients had follow-up brain MRIs within 6 months after disease onset, in which 13% (3/23) of patients showed normal features, and 87% (20/23) had abnormal brain MRI findings with various pictures, including generalized brain atrophy, and/or signal changes over the temporal lobes (Fig. 2) , cerebral cortexes, periventricular white matter (Fig. 3) , hippocampi, and basal ganglia. 48% (11/23) of patients showed abnormal signal intensity over the periventricular white matter. The extent of abnormal signal intensity over the periventricular white matter was grade 0 in 12 patients, grade 1 in 4, grade 2 in 2, and grade 3 in 5. As shown in Fig. 1b , 50% (6/12) of patients with grade 0 periventricular white matter lesion showed normal cognitive function. In contrast, all patients with grades 2 or 3 exhibited severe mental retardation or vegetative status.
As shown in Table 3 , 3 patients died of intracranial hemorrhage, acute hepatitis, or refractory arrhythmia at the acute stage of the disease course, and 3 patients were lost to follow-up. The remaining 23 patients had a median follow-up duration of 5 years, ranging from 0.5 to 13 years. Among them, 87% (20/23) of patients exhibited residual and/or refractory epilepsy, and the median number of AEDs administration was 3, ranging from 1 to 5. Regarding cognitive function, 26% (6/23) of patients had normal intelligence quotient, 26% (6/23) had learning disability and mild to moderate mental retardation, and 48% (11/23) had severe mental retardation or vegetative status. Three patients died of respiratory failure at 0.5 years, 3 years, and 8 years after disease onset. Table 3 Summary of demographic data, clinical manifestations, treatment methods, neuroimaging findings, and clinical outcomes in 29 patients with febrile infection related epilepsy syndrome (FIRES).
Febrile infection related epilepsy syndrome (FIRES)
Total number, N = 29
Discussion
The clinical manifestations and disease course of FIRES have been comprehensively described in the literature with welldefined inclusion and exclusion criteria [1, 11] . Male predominance in FIRES has been reported; [9] however, our case series showed female predominance. Although it is well known that FIRES is characterized by repetitive focal epilepsy with or without evolving to bilateral convulsive seizures occurring in a prolonged acute phase for more than two weeks and furthermore is too refractory to control, the complications during the period of hospitalization have rarely been mentioned in the literature.
Our study revealed FIRES patients presented with different degrees of liver function impairment, ranging from reversible injury with hepatomegaly or jaundice to irreversible liver failure, and hypersensitivity to AEDs resulting in skin rash or StevenJohnson syndrome. We observed if multiple AEDs were administrated within a short period, the occurrence and severity of skin rash increased. In addition, arrhythmia was frequently found during the acute stage. Two possible causes of arrhythmia were observed. First, multiple medications with adverse effects of arrhythmia, such as Phenytoin, Lidocaine, and inotropic agents, were administrated at the same time. Second, FIRES itself induced seizure-related neurogenic arrhythmia. One of our patients exhibited frequent arrhythmia accompanied by clinically seizures. The more frequent the seizures, the more obvious was the arrhythmia. The patient showed frequent torsades de pointes followed by sudden onset of cardiac asystole, which was rescued by cardiopulmonary resuscitation and intravenous Dormicum; then the patient immediately exhibited clinical seizures after cardiac rhythm was regained. We suggest that the prescription of AEDs be simplified to avoid potential conflict between the treatment and the risk of complications during the hospitalization. However, balancing the need for seizure control while simplifying AEDs is a considerable clinical challenge.
Regarding the treatment methods, high-dose phenobarbital has been shown to be effective in FIRES patients in the literature [14] . In addition to traditional AEDs, early ketogenic diet treatment could optimize both seizure control and cognitive outcome after FIRES [15] [16] [17] . IVIg showed a beneficial effect in a few isolated cases [18] . However, our case series revealed no patients on a ketogenic diet and/or receiving IVIg treatment showed improvement in seizure control or cognitive function. The use of burstsuppression coma is a standard care in super-refractory status epilepticus [19] . Nevertheless, in FIRES patients, poor cognitive outcome at follow-up might be associated with longer duration of anesthesia in FIRES patients [20] . We suggest that a treatment strategy for FIRES should be proposed to improve the clinical outcomes.
Chronological evolution of brain MRI findings in our case series progressed from initially normal findings to multifocal abnormal signal changes and diffuse brain atrophy. High signal intensity over the periventricular white matter of the frontal horn of the lateral ventricle was noted in half of our patients, which might represent focal demyelination change that would subside later. We observed that the higher the grade of the involved lesion in the periventricular white matter, the poorer the clinical outcome was. Focal abnormal high signal intensity was found not only over the periventricular white matter, but also at the bitemporal cortical areas, bilateral thalami, bilateral hippocampi and amygdala on follow-up neuroimaging studies, which were consistent with findings reported in the literature [21] [22] [23] . Whether these changes are due to prolonged intractable seizures or the disease entity itself remains uncertain. Further research on the underlying neuropathological mechanisms are needed.
FIRES is a devastating epilepsy syndrome. Despite aggressive medical treatments, the clinical outcomes are disappointing. In the literature, the mortality rate in the acute stage ranged from 0% to 20%, the residual/refractory epilepsy during long-term follow-up ranged from 83% to 100%, and severe mental retardation or vegetative status ranged from 28% to 38% [1, 5, 9, 10, 12, 24] . Our study showed similar results. More studies are needed to better understand the etiology and possible precipitating factors of this specific condition so that more effective treatment approaches can be developed, which may lead to improved clinical outcomes.
Conclusion
FIRES is a distressing catastrophic epileptic syndrome. Liver function impairment, skin rash, and arrhythmia are frequently seen during hospitalization in the acute stage of disease course. Chronological changes of brain MRI findings showed normal results, multifocal abnormal signal intensity at the bitemporal cortical areas, bilateral thalami, bilateral hippocampi and amygdala, and periventricular white matter of the frontal horn of the lateral ventricle. Higher grades of periventricular white matter lesions suggested poorer neurological outcomes. Half of our patients were classified as having severe mental retardation or vegetative status. Studies on the underlying pathomechanisms of FIRES are crucially needed in order to develop new treatment strategies, which may result in improved long-term outcomes.
